New study tests if a liquid diet can prevent dangerous aspiration in patients on popular diabetes drugs
NCT ID NCT06654219
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study looks at whether a clear liquid diet for 24 hours before anesthesia can reduce leftover stomach contents in patients taking GLP-1 drugs (like Ozempic). These drugs slow digestion, which can increase the risk of food or liquid entering the lungs during anesthesia. The study will compare two groups: one that follows the liquid diet and one that fasts normally. Researchers will measure stomach contents using ultrasound and check for side effects like thirst and hunger.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
clear liquid diet
What this could lead to
If successful, this could lead to safer fasting guidelines for patients on GLP-1 drugs before procedures, reducing the risk of lung aspiration.
What could go wrong
This is a small, early-phase study (136 participants) that only measures stomach contents, not actual aspiration events. Results may not apply to all patients or procedures.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PULMONARY ASPIRATION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
The University of Texas Health Science Center at Houston
RECRUITINGHouston, Texas, 77030, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••